EMA

RSS

CHMP recommends marketing authorization for Pfizer's Fablyn in osteoporosis

Dec. 29, 2008

Oncoscience withdraws Theraloc (nimotuzumab) marketing authorization application

Dec. 5, 2008

Further explanation of CHMP's negative opinion for Santhera's Sovrima for Friedreich's ataxia

Nov. 25, 2008

EMEA recommends temporary suspension of Acomplia marketing authorization in obese patients

Oct. 24, 2008

EMEA withdraws marketing authorization for Protopy in the European Union

Oct. 9, 2008

CHMP recommends variations to marketing authorization of Cancidas

Sep. 30, 2008

CHMP recommends marketing authorization for Azarga in open-angle glaucoma

Sep. 30, 2008

GSK withdraws European MAA for Quintanrix vaccine

Sep. 3, 2008

EMEA presents an update on reports of PML in MS patients treated with Tysabri

Aug. 14, 2008

CHMP recommends marketing authorization for GSK's prepandemic influenza vaccine

July 30, 2008